|
Takeda
|
4,413.00 |
|
-54.00 |
-1.21% |
6.11% |
2025-03-31 |
|
Daiichi Sankyo
|
3,511.00 |
|
-158.00 |
-4.31% |
-24.77% |
2025-03-31 |
|
Agios Pharmaceuticals
|
29.19 |
|
-1.09 |
-3.60% |
1.14% |
2025-03-31 |
|
Alnylam Pharmaceuticals
|
266.55 |
|
-1.91 |
-0.71% |
73.84% |
2025-03-31 |
|
Amgen
|
312.21 |
|
5.01 |
1.63% |
10.31% |
2025-03-31 |
|
Biogen
|
136.97 |
|
-1.48 |
-1.07% |
-36.24% |
2025-03-31 |
|
BioMarin Pharmaceutical
|
70.26 |
|
-1.18 |
-1.65% |
-19.33% |
2025-03-31 |
|
Exelixis
|
36.70 |
|
0 |
0% |
54.98% |
2025-03-31 |
|
Gilead Sciences
|
112.18 |
|
0.34 |
0.30% |
53.92% |
2025-03-31 |
|
Glaxosmithkline
|
38.80 |
|
0.06 |
0.14% |
-8.55% |
2025-03-31 |
|
Incyte
|
60.60 |
|
0 |
0% |
6.99% |
2025-03-31 |
|
MacroGenics
|
1.21 |
|
-0.05 |
-3.97% |
-91.37% |
2025-03-31 |
|
Moderna
|
28.35 |
|
-2.77 |
-8.90% |
-73.16% |
2025-03-31 |
|
Novartis
|
97.84 |
|
-0.78 |
-0.79% |
14.17% |
2025-03-31 |
|
Pfizer
|
25.35 |
|
0.16 |
0.64% |
-8.55% |
2025-03-31 |
|
PTC Therapeutics
|
49.89 |
|
-4.35 |
-8.02% |
74.50% |
2025-03-31 |
|
Ultragenyx Pharmaceutical
|
36.46 |
|
-1.36 |
-3.60% |
-22.38% |
2025-03-31 |
|
Regeneron Pharmaceuticals
|
635.08 |
|
-2.64 |
-0.41% |
-34.48% |
2025-03-31 |
|
Roche Holding
|
290.50 |
|
-6.20 |
-2.09% |
27.92% |
2025-03-31 |
|
Sarepta Therapeutics
|
65.09 |
|
-5.33 |
-7.56% |
-49.31% |
2025-03-31 |
|
TG Therapeutics
|
38.82 |
|
-1.04 |
-2.61% |
162.83% |
2025-03-31 |
|
Vertex Pharmaceuticals
|
484.93 |
|
-7.42 |
-1.51% |
15.33% |
2025-03-31 |